Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 1;27(7):1057–1066. doi: 10.1093/jamia/ocaa066

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020. Published by Oxford University Press on behalf of the American Medical Informatics Association.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 5. — Screenshot of gene and disease inclusion criteria for open trials investigating olaparib. This screenshot from the My Cancer Genome website shows the grouping of trials by disease and biomarker eligibility criteria that are investigating the use of olaparib. The total number of trials associated with each disease is shown on the data labels. The breakdown of the trials for each disease category can be viewed by hovering over the area of interest at the relevant My Cancer Genome web page (https://www.mycancergenome.org/content/drugs/olaparib/). The curated trial dataset (n = 5045) was used to calculate these numbers. Accessed 06/26/2019.